Pfizer–BioNTech COVID-19 vaksini - Haqqinda Melumat

ComiRNAty brendi altında satılanPfizer–BioNTech COVID-19 peyvəndi (INN: tozinaran), Almaniyanın BioNTech biotexnologiya şirkəti tərəfindən hazırlanmış və onun hazırlanmasında klinik sınaqlar, logistika və istehsal dəstəyi üçün Amerika şirkəti Pfizer ilə əməkdaşlıq edən mRNT əsaslı COVID-19 peyvəndidir. Peyvənd yolu ilə verilir. O, lipid nanohissəcikləri ilə əhatə olunmuş SARS-CoV-2-nin tam uzunluqlu sünbül zülalının mutasiya edilmiş formasını kodlayan nukleozidlə dəyişdirilmiş mRNT-dən (modRNT) ibarətdir. İlkin tövsiyədə peyvəndin 21 gün ara ilə iki dozada verilməli olduğu bildirilmişdi, lakin sonradan bu interval ABŞ-da 42 günə, Kanadada isə dörd aya qədər uzadıldı.

İstinadlar

^{[ölü keçid]}. European Medicines Agency (EMA). Retrieved 24 October 2021.
(Press release). U.S. Food and Drug Administration (FDA). 23 August 2021. from the original on 23 August 2021. Retrieved 23 August 2021.
Browne R (11 November 2020). . CNBC. from the original on 4 March 2021. Retrieved 14 January 2021.
Thomas K, Gelles D, Zimmer C (9 November 2020). . The New York Times. from the original on 23 November 2020. Retrieved 9 November 2020.
Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (October 2020). "". The New England JouRNTl of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279.
↑ 2021-03-02 at the Wayback Machine (PDF). U.S. Centers for Disease Control and Prevention (CDC). 28 September 2021. Retrieved 24 October 2021.
. ClinicalTrials.gov. 30 April 2020. from the original on 11 October 2020. Retrieved 5 August 2021.
Palca J (9 November 2020). . NPR.org. NPR. from the original on 9 November 2020. Retrieved 9 November 2020.
Herper M (9 November 2020). . Stat News. from the original on 9 November 2020. Retrieved 9 November 2020.
Ellis R. . WebMD. from the original on 4 may 2021. Retrieved 8 July 2021.
. ABC News. 4 March 2021. from the original on 26 July 2021. Retrieved 9 July 2021.
Public Health Agency of Canada (2 July 2021). (PDF). Health Canada (Report). (PDF) from the original on 23 June 2021. Retrieved 9 July 2021.

[1] {[ölü keçid]}. European Medicines Agency (EMA). Retrieved 24 October 2021.

[2] (Press release). U.S. Food and Drug Administration (FDA). 23 August 2021. from the original on 23 August 2021. Retrieved 23 August 2021.

[3] Browne R (11 November 2020). . CNBC. from the original on 4 March 2021. Retrieved 14 January 2021.

[4] Thomas K, Gelles D, Zimmer C (9 November 2020). . The New York Times. from the original on 23 November 2020. Retrieved 9 November 2020.

[5] Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (October 2020). "". The New England JouRNTl of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279.

[:0-6] 2021-03-02 at the Wayback Machine (PDF). U.S. Centers for Disease Control and Prevention (CDC). 28 September 2021. Retrieved 24 October 2021.

[7] . ClinicalTrials.gov. 30 April 2020. from the original on 11 October 2020. Retrieved 5 August 2021.

[8] Palca J (9 November 2020). . NPR.org. NPR. from the original on 9 November 2020. Retrieved 9 November 2020.

[9] Herper M (9 November 2020). . Stat News. from the original on 9 November 2020. Retrieved 9 November 2020.

[10] Ellis R. . WebMD. from the original on 4 may 2021. Retrieved 8 July 2021.

[11] . ABC News. 4 March 2021. from the original on 26 July 2021. Retrieved 9 July 2021.

[12] Public Health Agency of Canada (2 July 2021). (PDF). Health Canada (Report). (PDF) from the original on 23 June 2021. Retrieved 9 July 2021.